Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030

The global injection pen market is projected to reach USD 74.1 billion by 2030 from USD 47.0 billion in 2024, at a CAGR of 7.9% during the forecast period. The rapid growth in the geriatric population globally and the significant rise in the patients with chronic diseases such as diabetes and growth hormone disorders are expected to boost the demand for injection pen market. Moreover, gradual rise in utilization of self administration and increased focus on patient centric dsign and patient compliance are likely to support the market growth. Advancements in injection pen technology, new product launches, favourable reimbursement and government policies, investments in healthcare infrastructure, and initiatives to enhance the accessibility and affordability of injection pen is anticipated to fuel the market growth.

“The reusable injection pen segment of injection pen market to grow with the highest CAGR during the forecast period.”

Based on the injection pen market, the reusable injection pen segment is anticipated to grow at significant rate during forecast period. Due to increasing prevalence of chronic disease, ease of use and durability of reusable injection pen. These pens are more economical than disposable pens as they can be used multiple times by replacing the drug cartridge.Also, due to increased preference in self-administration and home care, there has been significant development and advancement in reusable injection pens. These factors are fostering the growth of injectable drug delivery at higher pace.

“The GLP-1 segment of diabetes therapy type segment to capture the largest market share of injection pen market.”

Based on therapy the injection pen market is segmented into into diabetes, growth hormone therapy, fertility, osteoporosis, obesity, and other therapies. The diabetes segment is further segmented into insulin and GLP-1 therapy types. GLP-1 segment register the higher CAGR during the forecast period. GLP-1-based therapies are used in treating diabetes mellitus due to their physiological properties and delivered through pen devices using thin and short needles. Owing to high R&D investments for developing GLP-1 therapies by prominent market players and recent advancements in GLP-1 injection pens are likely to propel the growth of this segment.

“North America accounted for the largest share of the injection pen market by region.”

The global injection penmarket is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for injection pen, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

The largest share of North America is attributed to the high disease burden of chronic disease such as diabetes contributing to a larger pool of patients requiring injection pen products. The presence of numerous potential market giants and favorable reimbursement policy in the region is likely to promote the growth of injection pen market in North America.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1–25%, Tier 2–30%, and Tier 3– 45%

By Designation: C-level–26%, Director-level–30%, and Others–44%

By Region: North America–40%, Europe–31%, Asia Pacific–20%, Latin America–6%, and the Middle East & Africa–3%

The major players operating in the injection pen market market are Novo Nordisk A/S (Denmark), Eli Lilly and Company (US), Sanofi (France), Ypsomed Holding AG (Switzerland), Becton, Dickinson and Company (US), Merck KGaA (Germany), AstraZeneca (UK), Owen Mumford (UK), Heselmeier (Germany), Sun Pharmaceutical Industries Ltd. (India), Pfizer Inc. (US), Biocon (India), Lupin (India), Wockhardt Ltd. (India) and Medtronic (Ireland).

Research Coverage

This report studies the injection pen market based on type, therapy, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Analysis of Key divers (increasing prevalence of chronic disease, technological advancement in injection pens, new product launches, favourable reimbursement scenario and government initiatives), restraints (stringent regulatory requirement , Opportunities (emerging markets, increasing focus on patient centric design and connected device ) , Challenge (lack of training and awareness, risk of injection site reactions)

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the injection pen market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the injection pen market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the injection pen market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030

Tables List

Table 1 Injection Pen Market: Inclusions And Exclusions

Table 2 Usd Conversion Rates, 2021–2023

Table 3 Classification Of Pen Injectors

Table 4 Import Data For Medicaments Containing Insulin In Measured Doses (Hs Code 300431), By Country, 2019–2023 (Usd Thousand)

Table 5 Export Data For Medicaments Containing Insulin In Measured Doses (Hs Code 300431), By Country, 2019–2023 (Usd Thousand)

Table 6 Injection Pen Market: Porter’s Five Forces Analysis

Table 7 Us Food And Drug Administration: Medical Device Classification

Table 8 Us: Medical Device Regulatory Approval Process

Table 9 Canada: Medical Device Regulatory Approval Process

Table 10 Japan: Medical Device Classification Under Pharmaceuticals And Medical Devices Agency

Table 11 China: Regulatory Bodies For Medical Device Approval

Table 12 China: Classification Of Medical Devices

Table 13 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 14 Europe: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 15 Asia Pacific: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 16 Latin America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 17 Middle East & Africa: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 18 Average Selling Price Trend Of Injection Pens, By Therapy, 2023 (Usd)

Table 19 Average Selling Price Trend Of Injection Pens, By Region,

2021–2023 (Usd)

Table 20 Key Conferences And Events, 2024–2025

Table 21 Influence Of Stakeholders On Buying Process, By End User

Table 22 Key Buying Criteria, By End User

Table 23 Case Study 1: Use Of Unopen Injector Pen For Accurate

Dosage Of Insulin

Table 24 Case Study 2: Adoption Of Pen Injector Platforms For

Improved Therapeutic Outcomes

Table 25 Reimbursement Codes

Table 26 End-user Expectations

Table 27 Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 28 Injection Pen Devices Market, By Type, 2022–2030 (Usd Million)

Table 29 Disposable Injection Pens Available In Market

Table 30 Injection Pen Market For Disposable Injection Pens, By Country,

2022–2030 (Usd Million)

Table 31 Injection Pen Market For Disposable Injection Pen Devices, By Country, 2022–2030 (Usd Million)

Table 32 Reusable Injection Pens Available In Market

Table 33 Injection Pen Market For Reusable Injection Pens, By Country,

2022–2030 (Usd Million)

Table 34 Injection Pen Market For Reusable Injection Pen Devices, By Country, 2022–2030 (Usd Million)

Table 35 Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 36 Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 37 Injection Pen Market For Diabetes Therapy, By Country,

2022–2030 (Usd Million)

Table 38 Injection Pens For Insulin Available In Market

Table 39 Injection Pen Market For Insulin Therapy, By Country,

2022–2030 (Usd Million)

Table 40 Injectable Drugs For Glucagon-like Peptide-1 Therapy In

Clinical Trial Phases

Table 41 Injection Pen Market For Glucagon-like Peptide-1 Therapy, By Country, 2022–2030 (Usd Million)

Table 42 Injection Pens For Growth Hormone Therapy Available In Market

Table 43 Injection Pen Market For Growth Hormone Therapy, By Country,

2022–2030 (Usd Million)

Table 44 Injection Pen Market For Osteoporosis Therapy, By Country,

2022–2030 (Usd Million)

Table 45 Injection Pen Market For Fertility Therapy, By Country,

2022–2030 (Usd Million)

Table 46 Injection Pen Market For Obesity Therapy, By Country,

2022–2030 (Usd Million)

Table 47 Injection Pen Market For Other Therapies, By Country,

2022–2030 (Usd Million)

Table 48 Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 49 Injection Pen Market For Home Care Settings, By Country,

2022–2030 (Usd Million)

Table 50 Injection Pen Market For Hospitals & Clinics, By Country,

2022–2030 (Usd Million)

Table 51 Injection Pen Market, By Region, 2022–2030 (Usd Million)

Table 52 North America: Injection Pen Market, By Country,

2022–2030 (Usd Million)

Table 53 North America: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 54 North America: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 55 North America: Injection Pen Market For Diabetes Therapy, By Type, 2022–2030 (Usd Million)

Table 56 North America: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 57 Us: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 58 Us: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 59 Us: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 60 Us: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 61 Canada: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 62 Canada: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 63 Canada: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 64 Canada: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 65 Europe: Injection Pen Market, By Country, 2022–2030 (Usd Million)

Table 66 Europe: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 67 Europe: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 68 Europe: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 69 Europe: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 70 Germany: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 71 Germany: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 72 Germany: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 73 Germany: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 74 France: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 75 France: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 76 France: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 77 France: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 78 Uk: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 79 Uk: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 80 Uk: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 81 Uk: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 82 Italy: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 83 Italy: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 84 Italy: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 85 Italy: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 86 Spain: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 87 Spain: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 88 Spain: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 89 Spain: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 90 Rest Of Europe: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 91 Rest Of Europe: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 92 Rest Of Europe: Injection Pen Market For Diabetes Therapy, By Type, 2022–2030 (Usd Million)

Table 93 Rest Of Europe: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 94 Asia Pacific: Injection Pen Market, By Country, 2022–2030 (Usd Million)

Table 95 Asia Pacific: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 96 Asia Pacific: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 97 Asia Pacific: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 98 Asia Pacific: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 99 Japan: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 100 Japan: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 101 Japan: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 102 Japan: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 103 China: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 104 China: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 105 China: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 106 China: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 107 India: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 108 India: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 109 India: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 110 India: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 111 South Korea: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 112 South Korea: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 113 South Korea: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 114 South Korea: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 115 Australia: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 116 Australia: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 117 Australia: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030(Usd Million)

Table 118 Australia: Injection Pen Market, By End User, 2022–2030(Usd Million)

Table 119 Rest Of Asia Pacific: Injection Pen Market, By Type,

2022–2030 (Usd Million)

Table 120 Rest Of Asia Pacific: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 121 Rest Of Asia Pacific: Injection Pen Market For Diabetes Therapy,

By Type, 2022–2030 (Usd Million)

Table 122 Rest Of Asia Pacific: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 123 Latin America: Injection Pen Market, By Country,

2022–2030 (Usd Million)

Table 124 Latin America: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 125 Latin America: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 126 Latin America: Injection Pen Market For Diabetes Therapy, By Type, 2022–2030 (Usd Million)

Table 127 Latin America: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 128 Brazil: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 129 Brazil: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 130 Brazil: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 131 Brazil: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 132 Mexico: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 133 Mexico: Injection Pen Market, By Therapy, 2022–2030 (Usd Million)

Table 134 Mexico: Injection Pen Market For Diabetes Therapy, By Type,

2022–2030 (Usd Million)

Table 135 Mexico: Injection Pen Market, By End User, 2022–2030 (Usd Million)

Table 136 Rest Of Latin America: Injection Pen Market, By Type,

2022–2030 (Usd Million)

Table 137 Rest Of Latin America: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 138 Rest Of Latin America: Injection Pen Market For Diabetes Therapy,

By Type, 2022–2030 (Usd Million)

Table 139 Rest Of Latin America: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 140 Middle East & Africa: Injection Pen Market, By Region,

2022–2030 (Usd Million)

Table 141 Middle East & Africa: Injection Pen Market, By Type,

2022–2030 (Usd Million)

Table 142 Middle East & Africa: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 143 Middle East & Africa: Injection Pen Market For Diabetes Therapy,

By Type, 2022–2030 (Usd Million)

Table 144 Middle East & Africa: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 145 Gcc Countries: Injection Pen Market, By Type, 2022–2030 (Usd Million)

Table 146 Gcc Countries: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 147 Gcc Countries: Injection Pen Market For Diabetes Therapy, By Type, 2022–2030 (Usd Million)

Table 148 Gcc Countries: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 149 Rest Of Middle East & Africa: Injection Pen Market, By Type,

2022–2030 (Usd Million)

Table 150 Rest Of Middle East & Africa: Injection Pen Market, By Therapy,

2022–2030 (Usd Million)

Table 151 Rest Of Middle East & Africa: Injection Pen Market For Diabetes Therapy, By Type, 2022–2030 (Usd Million)

Table 152 Rest Of Middle East & Africa: Injection Pen Market, By End User,

2022–2030 (Usd Million)

Table 153 Injection Pen Market: Degree Of Competition

Table 154 Injection Pen Market: Type Footprint

Table 155 Injection Pen Market: Therapy Footprint

Table 156 Injection Pen Market: Region Footprint

Table 157 Injection Pen Market: List Of Key Startups/Smes

Table 158 Injection Pen Market: Competitive Benchmarking Of Key Startups/Smes

Table 159 Injection Pen Market: Product Launches And Approvals,

January 2021–july 2024

Table 160 Injection Pen Market: Deals, January 2021–july 2024

Table 161 Injection Pen Market: Expansions, January 2021–july 2024

Table 162 Injection Pen Market: Other Developments, January 2021–july 2024

Table 163 Novo Nordisk A/S: Company Overview

Table 164 Novo Nordisk A/S: Products Offered

Table 165 Novo Nordisk A/S: Product Launches And Approvals,

January 2021— July 2024

Table 166 Novo Nordisk A/S: Deals, January 2021— July 2024

Table 167 Eli Lilly And Company: Company Overview

Table 168 Eli Lilly And Company: Products Offered

Table 169 Eli Lilly And Company: Deals, January 2021— July 2024

Table 170 Eli Lilly And Company: Expansions, January 2021— July 2024

Table 171 Sanofi: Company Overview

Table 172 Sanofi: Products Offered

Table 173 Sanofi: Deals, January 2021— July 2024

Table 174 Ypsomed Holding Ag: Company Overview

Table 175 Ypsomed Holding Ag: Products Offered

Table 176 Ypsomed Holding Ag: Expansions, January 2021— July 2024

Table 177 Ypsomed Holding Ag: Other Developments, January 2021— July 2024

Table 178 Becton, Dickinson And Company: Company Overview

Table 179 Becton, Dickinson And Company: Products Offered

Table 180 Merck Kgaa: Company Overview

Table 181 Merck Kgaa: Products Offered

Table 182 Astrazeneca: Company Overview

Table 183 Astrazeneca: Products Offered

Table 184 Astrazeneca: Product Launches And Approvals,

January 2021— July 2024

Table 185 Owen Mumford: Company Overview

Table 186 Owen Mumford: Products Offered

Table 187 Haselmeier: Company Overview

Table 188 Haselmeier: Products Offered

Table 189 Sun Pharmaceutical Industries Ltd.: Company Overview

Table 190 Sun Pharmaceutical Industries Ltd.: Products Offered

Table 191 Pfizer Inc.: Company Overview

Table 192 Pfizer Inc.: Products Offered

Table 193 Biocon: Company Overview

Table 194 Biocon: Products Offered

Table 195 Biocon: Product Launches And Approvals, January 2021— July 2024

Table 196 Biocon: Deals, January 2021— July 2024

Table 197 Lupin: Company Overview

Table 198 Lupin: Products Offered

Table 199 Wockhardt Ltd.: Company Overview

Table 200 Wockhardt Ltd.: Products Offered

Table 201 Medtronic: Company Overview

Table 202 Medtronic: Products Offered

Table 203 Medtronic: Product Launches And Approvals, January 2021— July 2024

Table 204 Gerresheimer Ag: Company Overview

Table 205 Shaily Engineering Plastics Ltd.: Company Overview

Table 206 Shl Medical Ag: Company Overview

Table 207 Emperra Gmbh E-health Technologies: Company Overview

Table 208 Nemera France Sas: Company Overview

Table 209 Jiangsu Delfu Medical Device Co., Ltd.: Company Overview

Table 210 Solteam Medical: Company Overview

Table 211 Philip-medisize- A Molex Company: Company Overview

Table 212 Stevanto Group: Company Overview

Table 213 Wanhai Medical Instruments Co., Ltd.: Company Overview

Figures List

Figure 1 Injection Pen Market Segmentation

Figure 2 Research Design

Figure 3 Primary Sources

Figure 4 Injection Pen Market: Breakdown Of Primary Interviews

(By Company Type, Designation, And Region)

Figure 5 Injection Pen Market: Breakdown Of Primary Interviews:

Supply-side And Demand-side Participants

Figure 6 Market Size Estimation: Supply-side Analysis

Figure 7 Market Size Estimation Based On Revenue Share Analysis

Figure 8 Illustrative Example Of Novo Nordisk A/S: Revenue Share

Analysis, 2023

Figure 9 Market Size Estimation For Injection Pen Devices Based

On Revenue Share Analysis

Figure 10 Illustrative Example Of Ypsomed Ag: Revenue Share Analysis, 2023

Figure 11 Injection Pen Market: Top-down Approach

Figure 12 Cagr Projections: Supply-side Analysis

Figure 13 Data Triangulation

Figure 14 Injection Pen Market, By Type, 2024 Vs. 2030 (Usd Million)

Figure 15 Injection Pen Market, By Therapy, 2024 Vs. 2030 (Usd Million)

Figure 16 Injection Pen Market For Diabetes Therapy, By Type,

2024 Vs. 2030(Usd Million)

Figure 17 Injection Pen Market, By End User, 2024 Vs. 2030 (Usd Million)

Figure 18 Geographical Snapshot Of Injection Pen Market, 2024–2029

Figure 19 Growing Prevalence Of Chronic Diseases To Drive Market

Figure 20 Diabetes Segment And Japan Accounted For Largest Shares

In Asia Pacific Injection Pen Market In 2023

Figure 21 China To Register Highest Growth During Forecast Period

Figure 22 Developing Markets To Account For Higher Growth

During Forecast Period

Figure 23 Injection Pen Market: Drivers, Restraints, Opportunities,

And Challenges

Figure 24 Patients With Chronic Diseases In Us, 1995–2030 (Million)

Figure 25 Estimated Diabetic Population, By Region, 2029 Vs. 2030 Vs.

2040 (Million)

Figure 26 Revenue Shift And New Revenue Pockets For Injection Pen Providers

Figure 27 Injection Pen Market: Supply Chain Analysis

Figure 28 Injection Pen Market: Porter’s Five Forces Analysis

Figure 29 Injection Pen Market: Value Chain Analysis

Figure 30 Canada: Class Ii Medical Device Approval Process

Figure 31 Europe: Ce Approval Process For Class Iia Medical Devices

Figure 32 Patents Granted Worldwide, January 2014–june 2024

Figure 33 Patent Analysis, January 2014–june 2024

Figure 34 Average Selling Price Trend Of Insulin Pens, By Key Player, 2023 (Usd)

Figure 35 Average Selling Price Trend Of Glp-1 Pens, By Key Player, 2023 (Usd)

Figure 36 Influence Of Stakeholders On Buying Process, By End User

Figure 37 Key Buying Criteria, By End User

Figure 38 Injection Pen Market: Ecosystem Analysis

Figure 39 Investment And Funding Scenario, 2018–2022

Figure 40 North America: Injection Pen Market Snapshot

Figure 41 Asia Pacific: Injection Pen Market Snapshot

Figure 42 Revenue Analysis Of Key Players In Injection Pen Market, 2021–2023

Figure 43 Market Share Analysis Of Key Players In Injection Pen Market, 2023

Figure 44 Injection Pen Market: Company Evaluation Matrix, 2023

Figure 45 Injection Pen Market: Company Footprint

Figure 46 Injection Pen Market: Company Evaluation Matrix

(Startups/Smes), 2023

Figure 47 Ev/Ebitda Of Key Vendors

Figure 48 Year-to-date (Ytd) Price Total Return And 5-year Stock

Beta Of Key Vendors

Figure 49 Injection Pen Market: Brand/Product Comparison

Figure 50 Novo Nordisk A/S: Company Snapshot (2023)

Figure 51 Eli Lilly And Company: Company Snapshot (2023)

Figure 52 Sanofi: Company Snapshot (2023)

Figure 53 Ypsomed Holding Ag: Company Snapshot (2023)

Figure 54 Becton, Dickinson And Company: Company Snapshot (2023)

Figure 55 Merck Kgaa: Company Snapshot (2023)

Figure 56 Astrazeneca: Company Snapshot (2023)

Figure 57 Sun Pharmaceutical Industries Ltd.: Company Snapshot (2023)

Figure 58 Pfizer Inc.: Company Snapshot (2023)

Figure 59 Biocon: Company Snapshot (2023)

Figure 60 Lupin: Company Snapshot (2023)

Figure 61 Wockhardt Ltd.: Company Snapshot (2023)

Figure 62 Medtronic: Company Snapshot (2023)